Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsJonae Barnes - Senior Vice President of ...

Patient Enrollment on Track in Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV), Topline Results from North ...

Okay, so the sensational pilot episode of Pluribus does open in mysterious fashion, to be fair. Researchers working at a ...

As PET scans fall short, blood-based circulating tumor DNA testing shows promise in monitoring large B-cell lymphoma ...

Kygevvi (doxecitine and doxribtimine) earned FDA approval as the first treatment for thymidine kinase 2 deficiency, supported by data from a Phase II trial and multiple retrospective studies showing ...

The research team led by Research Professor Jaeyong Lee at the Institute for Cellular Differentiation and Aging, College of Medicine, Hallym ...

D espite being almost genetically identical to modern humans, Neanderthals had much chunkier faces, with big noses, ...

Researchers from Skoltech, the University of Potsdam, and the Massachusetts Institute of Technology have discovered a ...

This article introduces the field of bioinformatics and its importance as a cornerstone of biological research, as well as ...

Medivir AB ( ($SE:MVIR) ) has shared an update. Medivir AB held an extraordinary general meeting where several key resolutions were adopted, ...

Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights that advance precision health, today announced a groundbreaking ...

The 2024 Nobel Prize in Physiology or Medicine was awarded to Victor Ambros and Gary Ruvkun for their groundbreaking ...